Here, VEGF receptor tyrosine kinases are inhibited (along with other major angiogenic tyrosine kinase receptors), which inhibits tumor angiogenesis and thus leads to a sharp increase in cell death (Figure 8B.3) compared to non-treated tumors, which is consistent with previous studies using nintedanib [79]. Here, NTRK1 is linked to neoplasm.